Indexed with PubMed and Science Citation Index (E) 
Users online: 2225 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (970 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded163    
    Comments [Add]    
    Cited by others 4    

Recommend this journal


Year : 2010  |  Volume : 76  |  Issue : 4  |  Page : 448

Lupus erythematosus profundus

Department of Dermatology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India

Date of Web Publication21-Jul-2010

Correspondence Address:
T Narayana Rao
Res:15-14-15, Doctor`s Enclave, Near collectors office, Opp. Sagar Lodge, Visakhapatnam - 530 002
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.66612

Rights and Permissions

How to cite this article:
Rao T N, Ahmed K, Venkatachalam K. Lupus erythematosus profundus. Indian J Dermatol Venereol Leprol 2010;76:448

How to cite this URL:
Rao T N, Ahmed K, Venkatachalam K. Lupus erythematosus profundus. Indian J Dermatol Venereol Leprol [serial online] 2010 [cited 2020 Nov 25];76:448. Available from:


In 1883, Kaposi, [1] first, described the association of subcutaneous nodules with lupus erythematosus. This finding has subsequently being recognized as LE profundus, more accurately, LE panniculitis (LEP). In 1956, Arnold. [2] reviewed the literature and helped substantiate the existence of this entity. LEP is an unusual but distinct clinical variety of lupus erythematosus. The inflammatory reaction in LEP takes place primarily in the deep corium and the subcutaneous tissues leading to deep indurated nodules or sharply defined plaques. The overlying skin usually appears normal, but there may be erythema, atrophy, ulceration or poikilodermatous or hyperkeratotic changes. [3] The lesions are most frequent on cheeks but other sites of predilection are face, upper arms, hands, chest, buttocks and thighs. [4]

A 39-year-old female presented with his­tory of development of a single, asymptomatic, erythematous plaque in the upper part of left arm since four years. The lesion, initially, was about 1 Χ 2 cm 2 in size, oval in shape and firm in consis­tency. It gradually increased in size to about 8 Χ 5 cm 2 was firm to hard in consistency. There was no history of pre­ceding trauma. No history of taking injection. Patient had myalgia, but no other systemic symptoms. Examination revealed a large erythematous plaque about 8 Χ 5 cm 2 present over the lateral aspect of the left arm [Figure 1] with well-defined mar­gins, sharply demarcated from the surrounding normal skin, firm to hard in consistency and non-ten­der. There was no lymphadenopathy.

The following laboratory tests were done which showed normal results: complete blood cell count, differential cell count, ESR, total serum proteins with A:G ratio, blood sugar, blood urea, serum creatinine, serum electrolytes, liver function tests and urinalysis. X-ray chest was normal. Rheumatoid factor was negative. Blood for LE cells was normal. Connective tissue profile showed antinuclear antibodies positive in 1:100 titre by direct immunoflourescence method, but anti ds DNA and Anti Sm, Anti RNP, Anti Ro, Anti La, Scl antibodies were negative.

Skin biopsy showed septal and lobular panniculitis [Figure 2] without vasculitis with widened septae and infiltration by moderately dense infiltrate of lymphocytes. The infiltration is spilled into the periphery of the lobules forming lace like network, particularly close to the septa. Overlying dermis is uninvolved. The dermoepidermal junction is infiltrated by lymphocytes. The basement membrane zone is thickened and basal layer showed vacuolar type of degeneration. Mucin staining was not done.

Immunofluorescence studies were done on both lesional and non lesional skin, which showed linear depositis of IgG, IgM and C3 along the basement membrane zone in the lesional skin [Figure 3] and negative results in the non-lesional skin.

LEP may develop in association with discoid lupus erythematosus (DLE) or systemic lupus erythematosus (SLE) or may occur as an isolated phenomenon. [5]

It is to be differentiated from panniculitis due to other connective tissue diseases, like dermatomyositis and scleroderma and from Weber-Christian disease, protease inhibitor deficiencies, erythema nodosum, lipodystrophies and sarcoidosis. [6] Most of the reported patients are middle aged but some childhood cases (7-18 years) have been recorded.

In our patient, there was no history of pho­tosensitivity, oral ulcer­ation, arthral­gia or neurop­sychiatric manifesta­tions. Family history was negative. The antinuclear antibody was positive and lesional lupus band test was positive. This case is reported for its difficulty in diagnosis.

The patient was given 200 mg of Hydroxychloroquine twice daily, orally, along with 40 mg of prednisolone daily, orally, which led to significant improvement after six months.

  References Top

1.Arnold HL Jr. Lupus erythematosus profundus: Commentary and report on four more cases. AMA Arch Dermatol 1956;73:15-33.  Back to cited text no. 1      
2.Arnold HL Jr. Lupus erythematosus profundus (Kaposi-Irgang): Historical review and report of a case. Arch Derm Syphilol 1948;57:196-203.  Back to cited text no. 2      
3.Black MM, Cunliffe WJ. Inflammatory disorders of subcutaneous fat. In: Champion RH, Burton JL, Burns DA, et al., editors. Textbook of Dermatology. London: Blackwell Science LTD; 1998. p. 2420-1.  Back to cited text no. 3      
4.Tuffanelli DL. Lupus erytheratosus panniculitis (profundus). Arch Dermatol 1971;103:231-42.  Back to cited text no. 4      
5.Taοeb A, Hehunstre JP, Goetz J, Surlθve Bazeille JE, Fizet D, Hauptmann G, et al. Lupus erythematosus panniculitis with partial genetic deficiency of C2 and C4 in a child. Arch Dermatol 1986;122:576-82.  Back to cited text no. 5      
6.Kamal A, VK Jain, Surbhi D. Lupus erythematosus profundus. Indian J Dermatol Venereol Leprol 2002;68:352-3.  Back to cited text no. 6      


  [Figure 1], [Figure 2], [Figure 3]

This article has been cited by
1 The use of glucocorticoids in Systemic Lupus Erythematosus. After 60years still more an art than science
Remco K.M.A.C. Luijten,Ruth D. Fritsch-Stork,Johannes W.J. Bijlsma,Ronald H.W.M. Derksen
Autoimmunity Reviews. 2013; 12(5): 617
[Pubmed] | [DOI]
2 A Case of Facial Lipoatrophy Secondary to Lupus Profundus Managed with Lipofilling Technique
Luigi Valdatta,Mario Cherubino,Federico Tamborini,Igor Pellegatta,Francesca Maggiulli
Case Reports in Dermatological Medicine. 2012; 2012: 1
[Pubmed] | [DOI]
3 Lupus erythematosus panniculitis: A case report
Koley, S., Sarkar, J., Choudhary, S.V., Choudhury, M., Banerjee, G., Bar, C., Chatterjee, T.
Journal of Pakistan Association of Dermatologists. 2011; 21(2): 118-121
4 Lupus erythematosus profundus
Rao, T.N., Ahmed, K., Venkatachalam, K.
Indian Journal of Dermatology, Venereology and Leprology. 2010; 76(4): 448


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow